Addition of obinutuzumab or rituximab to chlorambucil improves outcomes for chronic lymphocytic leukaemia

Strategies to maintain remission in high risk CD19 lymphoid malignancies

Von Willebrand Factor and ADAMTS13

Use of autologous stem cell transplant in multiple myeloma

Study shows pomalidomide prolongs survival in refractory myeloma patients

Use of Daratumumab, a CD38 monoclonal antibody, in advanced multiple myeloma

Targeting JAK-STAT pathway in malignant and non-malignant cells in myeloproliferative neoplasms

Addition of obinutuzumab or rituximab to chlorambucil for chronic lymphocytic leukaemia

Daratumumab, a CD38 monoclonal antibody study in advanced multiple myeloma

Vemurafenib and ipilimumab for metastatic melanoma

Phase I study measures effect of ipilimumab and nivolumab combination in melanoma patients

Comment on progression free survival in lung cancer patients and the GALAXY-1 trial